Nakanishi Inc.

7716.T
Medical Instruments & Supplies
2026/11/13 12:49 Updated
Market Cap: $1.4B (¥231.2B)
Stock Price: $8.85 (¥1,413)
Exchange Rate: 1 USD = ¥159.74

Fiscal Year Ending December 2026 — Third Quarter Financial Summary (Japanese GAAP) (Consolidated)

For the nine months ended the third quarter of the fiscal year ending December 2026, net sales were 70,399 hundred million yen (YoY +19.8%), EBITDA was 21,190 hundred million yen, operating income was 16,014 hundred million yen, ordinary income was 17,061 hundred million yen, and quarterly net income attributable to owners of parent was 12,492 hundred million yen, representing substantial year-over-year increases. A stock split has been implemented.

Importance:
Page Updated: November 13, 2026
IR Disclosure Date: November 13, 2026

Key Figures

  • Net Sales: 70,399,973 thousand yen (YoY +19.8%)
  • EBITDA: 21,189,910 thousand yen (YoY +43.3%)
  • Quarterly Net Income Attributable to Owners of Parent: 12,492,451 thousand yen (YoY +102.1%)

AI要約

Performance Overview

Net sales and profits were robust across all four segments — Dental, DCI, Surgical, and Machinery — resulting in nine-month cumulative net sales of 70,399 hundred million yen, EBITDA of 21,190 hundred million yen, operating income of 16,014 hundred million yen, ordinary income of 17,061 hundred million yen, and quarterly net income attributable to owners of parent of 12,492 hundred million yen, significantly exceeding the prior-year period. A stock split was implemented effective October 1.

Outlook and Impact

The full-year forecast remains unchanged: net sales 94,480 hundred million yen, EBITDA 24,340 hundred million yen, operating income 18,649 hundred million yen, ordinary income 19,062 hundred million yen, and net income attributable to owners of parent 13,544 hundred million yen. Earnings per share, adjusted for the stock split, are 81.55 yen (split reflected). Growth trends are maintained across all segments, and financial soundness remains high, with a shareholders' equity ratio of 69.2%.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Nakanishi Inc.

Company overview · Stock price · Financial data · All IR

View company page →